Es gab 50 kürzliche Insider-Transaktionen für ALX Oncology Holdings Inc. (ALXO), darunter 34 Käufe und 12 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $12.65M und die gesamten Insider-Verkäufe auf $47.43K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Lettmann Jason, Pinto Shelly, Klencke Barbara. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ALXO
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-19 |
Lettmann Jason |
Chief Executive Officer |
Informierter Verkauf |
12,311 |
$2.17 |
$26.71K |
293,609 |
| 2026-03-19 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
903 |
$2.17 |
$1.96K |
86,805 |
| 2026-03-03 |
Klencke Barbara |
Chief Medical Officer |
RSU-Zuteilung |
700,000 |
$2.07 |
$1.45M |
700,000 |
| 2026-02-25 |
Klencke Barbara |
Chief Medical Officer |
Unbekannt |
100,000 |
$1.48 |
$148K |
- |
| 2026-02-18 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
565 |
$2.27 |
$1.28K |
87,708 |
| 2026-02-17 |
Lettmann Jason |
Chief Executive Officer |
RSU-Steuereinbehalt |
2,201 |
$2.27 |
$5K |
305,920 |
| 2026-02-02 |
Goodman Corey S |
10 Percent Owner |
Informierter Kauf |
3,184,713 |
$1.57 |
$5M |
8,453,038 |
| 2026-01-26 |
Lettmann Jason |
Chief Executive Officer |
RSU-Zuteilung |
912,000 |
$1.48 |
$1.35M |
912,000 |
| 2026-01-26 |
Pinto Shelly |
SVP, Finance and CAO |
RSU-Zuteilung |
192,000 |
$1.48 |
$284.16K |
192,000 |
| 2026-01-26 |
Shantharam Harish |
Chief Financial Officer |
RSU-Zuteilung |
303,000 |
$1.48 |
$448.44K |
303,000 |
| 2026-01-20 |
Goodman Corey S |
10 Percent Owner |
RSU-Zuteilung |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Garland J. Scott |
Director |
RSU-Zuteilung |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Takimoto Chris H |
Director |
RSU-Zuteilung |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Hemrajani Rekha |
Director |
RSU-Zuteilung |
40,400 |
$1.32 |
$53.33K |
40,400 |
| 2026-01-20 |
Sandler Alan B. |
Director |
RSU-Zuteilung |
10,100 |
$1.32 |
$13.33K |
10,100 |
| 2026-01-20 |
Curran Daniel J. |
Director |
RSU-Zuteilung |
16,833 |
$1.32 |
$22.22K |
16,833 |
| 2026-01-06 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
3,925 |
$1.11 |
$4.36K |
88,273 |
| 2025-10-14 |
Lettmann Jason |
Chief Executive Officer |
RSU-Zuteilung |
597,500 |
$1.70 |
$1.02M |
597,500 |
| 2025-10-14 |
Pinto Shelly |
SVP, Finance and CAO |
RSU-Zuteilung |
140,000 |
$1.70 |
$238K |
140,000 |
| 2025-10-14 |
Shantharam Harish |
Chief Financial Officer |
RSU-Zuteilung |
198,750 |
$1.70 |
$337.88K |
198,750 |
| 2025-09-17 |
Lettmann Jason |
Chief Executive Officer |
Informierter Kauf |
71,163 |
$1.08 |
$76.89K |
305,121 |
| 2025-09-17 |
Klencke Barbara |
Director |
RSU-Zuteilung |
300,000 |
$1.05 |
$315K |
300,000 |
| 2025-09-16 |
Lettmann Jason |
Chief Executive Officer |
Informierter Kauf |
21,070 |
$1.07 |
$22.46K |
233,958 |
| 2025-08-18 |
Shantharam Harish |
Chief Financial Officer |
Informierter Kauf |
75,000 |
$0.78 |
$58.4K |
75,000 |
| 2025-08-15 |
Lettmann Jason |
Chief Executive Officer |
Informierter Verkauf |
2,382 |
$0.64 |
$1.53K |
212,888 |
| 2025-08-15 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
611 |
$0.64 |
$391.28 |
89,198 |
| 2025-08-12 |
Curran Daniel J. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-08-12 |
Curran Daniel J. |
Director |
RSU-Zuteilung |
40,400 |
$0.62 |
$24.85K |
40,400 |
| 2025-07-07 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
2,011 |
$0.45 |
$905.15 |
86,809 |
| 2025-06-30 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
1,532 |
$0.43 |
$658.76 |
88,820 |
| 2025-04-11 |
Lettmann Jason |
Chief Executive Officer |
RSU-Zuteilung |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-04-11 |
Sandler Alan B. |
Chief Medical Officer |
RSU-Zuteilung |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-04-11 |
Pinto Shelly |
SVP, Finance and CAO |
RSU-Zuteilung |
90,000 |
$0.49 |
$44.1K |
90,000 |
| 2025-04-11 |
Shantharam Harish |
Chief Financial Officer |
RSU-Zuteilung |
125,000 |
$0.49 |
$61.25K |
125,000 |
| 2025-03-14 |
Lettmann Jason |
Chief Executive Officer |
RSU-Zuteilung |
42,000 |
- |
- |
212,270 |
| 2025-03-14 |
Pinto Shelly |
SVP, Finance and CAO |
RSU-Zuteilung |
3,000 |
- |
- |
90,352 |
| 2025-02-19 |
Lettmann Jason |
Chief Executive Officer |
Informierter Verkauf |
2,159 |
$1.15 |
$2.48K |
170,270 |
| 2025-02-19 |
Pons Jaume |
President & CSO |
Informierter Verkauf |
1,326 |
$1.15 |
$1.53K |
579,388 |
| 2025-02-19 |
Pinto Shelly |
SVP, Finance and CAO |
Informierter Verkauf |
550 |
$1.15 |
$632.61 |
87,352 |
| 2025-01-21 |
Goodman Corey S |
10 Percent Owner |
RSU-Zuteilung |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Garland J. Scott |
Director |
RSU-Zuteilung |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Klencke Barbara |
Director |
Unbekannt |
- |
- |
- |
60,000 |
| 2025-01-21 |
Klencke Barbara |
Director |
RSU-Zuteilung |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Lettmann Jason |
Chief Executive Officer |
RSU-Zuteilung |
478,000 |
$1.65 |
$788.7K |
478,000 |
| 2025-01-21 |
Takimoto Chris H |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-01-21 |
Takimoto Chris H |
Director |
RSU-Zuteilung |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Hemrajani Rekha |
Director |
RSU-Zuteilung |
40,400 |
$1.65 |
$66.66K |
40,400 |
| 2025-01-21 |
Pons Jaume |
President & CSO |
RSU-Zuteilung |
50,000 |
$1.65 |
$82.5K |
50,000 |
| 2025-01-21 |
Sandler Alan B. |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$1.65 |
$165K |
100,000 |
| 2025-01-21 |
Pinto Shelly |
SVP, Finance and CAO |
RSU-Zuteilung |
112,000 |
$1.65 |
$184.8K |
112,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
